1. Home
  2. JFB vs CASI Comparison

JFB vs CASI Comparison

Compare JFB & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JFB
  • CASI
  • Stock Information
  • Founded
  • JFB 2014
  • CASI 1991
  • Country
  • JFB United States
  • CASI China
  • Employees
  • JFB N/A
  • CASI N/A
  • Industry
  • JFB
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • JFB
  • CASI Health Care
  • Exchange
  • JFB NYSE
  • CASI Nasdaq
  • Market Cap
  • JFB 35.3M
  • CASI 33.4M
  • IPO Year
  • JFB 2025
  • CASI 1996
  • Fundamental
  • Price
  • JFB $4.06
  • CASI $2.10
  • Analyst Decision
  • JFB
  • CASI Strong Buy
  • Analyst Count
  • JFB 0
  • CASI 1
  • Target Price
  • JFB N/A
  • CASI $6.00
  • AVG Volume (30 Days)
  • JFB 73.3K
  • CASI 8.5K
  • Earning Date
  • JFB 01-01-0001
  • CASI 03-31-2025
  • Dividend Yield
  • JFB N/A
  • CASI N/A
  • EPS Growth
  • JFB N/A
  • CASI N/A
  • EPS
  • JFB 0.19
  • CASI N/A
  • Revenue
  • JFB $27,273,091.00
  • CASI $28,537,000.00
  • Revenue This Year
  • JFB N/A
  • CASI N/A
  • Revenue Next Year
  • JFB N/A
  • CASI $134.79
  • P/E Ratio
  • JFB $22.64
  • CASI N/A
  • Revenue Growth
  • JFB 12.72
  • CASI N/A
  • 52 Week Low
  • JFB $3.39
  • CASI $2.04
  • 52 Week High
  • JFB $4.87
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • JFB N/A
  • CASI 42.35
  • Support Level
  • JFB N/A
  • CASI $2.10
  • Resistance Level
  • JFB N/A
  • CASI $2.52
  • Average True Range (ATR)
  • JFB 0.00
  • CASI 0.21
  • MACD
  • JFB 0.00
  • CASI 0.00
  • Stochastic Oscillator
  • JFB 0.00
  • CASI 12.50

About JFB JFB CONSTRUCTION HOLDINGS

JFB Construction Holdings is a commercial and residential real estate construction and development company. It is engaged in retail corporate buildouts, multifamily community developments and luxury residential homes, with a focus on fostering long-term relationships with clients, partners, and communities. The company operates in three distinct business segments: Commercial Construction, Residential Construction, and Real Estate Development. Key revenue is generated from Commercial Construction: This segment includes all activities related to the construction of commercial properties such as office buildings, retail spaces, and industrial facilities.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: